跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RANOLAZINA TEVA 500 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RANOLAZINA TEVA 500 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Approved
STANDARD
RANOLAZINA TEVA 500 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Teva Pharma S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 9, 2024
Approval ID
d84c86a1eb59bc1d
Company
Teva Pharma S.L.U.
Type
Standard
Approval Details
Approval Id
d84c86a1eb59bc1d
Drug Cima Aemps Name
RANOLAZINA TEVA 500 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Register Number
89227
Holder Company Name
Teva Pharma S.L.U.
Marketing Company Name
Teva Pharma S.L.U.
Authorization Date
2024-01-09
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
500 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Teva Pharma S.L.U.
Active Ingredients
RANOLAZINA
500 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 9, 2024
Approval ID
d84c86a1eb59bc1d
Type
Standard
Back to CIMA-AEMPS Approvals